BioCatalyst

JAB-2485 (Aurora A inhibitor), JAB-2485 (Aurora A inhibitor) — catalyst calendar

1 verified catalyst event(s) referencing JAB-2485 (Aurora A inhibitor), JAB-2485 (Aurora A inhibitor), each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Phase 1/2 · Solid Tumors, ER+ Breast Cancer
 Jacobio Pharmaceuticals Co., Ltd. JAB-2485 (Aurora A inhibitor), JAB-2485 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.